NCT00000353已完成2 期
Efficacy/Safety Trial of Buprenorphine/Nx for Opiate Dependence
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 试验地点
- 2
研究概览
简要总结
The purpose of this study is to determine the efficacy and safety of a buprenorphine/naloxone sublingual tablet formulation as an office-based therapy for opiate dependence treatment.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 19 Years 至 57 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
已完成
2 期
Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9Opioid-Related DisordersNCT00000344National Institute on Drug Abuse (NIDA)40
已完成
2 期
Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1Opioid-Related DisordersSubstance-Related DisordersNCT00015028National Institute on Drug Abuse (NIDA)
已完成
3 期
Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1Heroin DependenceSubstance-Related DisordersNCT00015171National Institute on Drug Abuse (NIDA)
撤回
2 期
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1Heroin DependenceOpioid-Related DisordersNCT00000326University of Colorado, Denver
已完成
4 期
Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14Opioid DependenceSubstance-Related DisordersNCT00015340National Institute on Drug Abuse (NIDA)582